Search

everythinglearnresearchcommunity

for

Search:↓

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Aging causes changes in the scalp that can affect hair growth and lead to older-looking hair in women.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

Widened sweat ducts are a very specific sign of scarring hair loss.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

Baldness score can't be used to predict prostate size.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The hair serum significantly improved hair growth and reduced hair fall without causing any skin issues.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Modified stem cells from umbilical cord blood can make hair grow faster.

The document concludes that activating hair roots is important for improving hair growth and preventing hair loss.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Using a fractional laser can stimulate hair growth, but the intensity and duration of inflammation are crucial. Too much can cause ulcers and scarring. Lower beam energy and fewer treatments are recommended to avoid damage.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The document doesn't provide enough information to summarize.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.